These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10791446)

  • 1. Symptom severity and oesophageal chemosensitivity to acid in older and young patients with gastro-oesophageal reflux.
    Fass R; Pulliam G; Johnson C; Garewal HS; Sampliner RE
    Age Ageing; 2000 Mar; 29(2):125-30. PubMed ID: 10791446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oesophageal sensation in response to high PCO(2) and acidic solutions in nonerosive reflux disease.
    Hershcovici T; Poh CH; Fass OZ; Ashpole N; Akiba Y; Guillén-Rodríguez JM; Kaunitz JD; Fass R
    Eur J Clin Invest; 2012 Feb; 42(2):195-202. PubMed ID: 21679182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered sensorimotor responses to esophageal acidification in older adults with GERD.
    Chen CL; Yi CH; Liu TT; Orr WC
    Scand J Gastroenterol; 2010 Oct; 45(10):1150-5. PubMed ID: 20545468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evaluation of acid-induced changes in oesophageal mucosa integrity and sensitivity in non-erosive reflux disease.
    Woodland P; Al-Zinaty M; Yazaki E; Sifrim D
    Gut; 2013 Sep; 62(9):1256-61. PubMed ID: 22722617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid sensitization of esophageal mucosal afferents: implication for symptom perception in patients across the gastroesophageal reflux disease spectrum.
    Szczesniak MM; Fuentealba SE; Cook IJ
    Clin J Pain; 2013 Jan; 29(1):70-7. PubMed ID: 22330131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M; Manno M; De Micheli E; Savarino V
    Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease.
    Cicala M; Emerenziani S; Caviglia R; Guarino MP; Vavassori P; Ribolsi M; Carotti S; Petitti T; Pallone F
    Aliment Pharmacol Ther; 2003 Sep; 18(6):605-13. PubMed ID: 12969087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic gastro-oesophageal reflux, abnormal oesophageal acid exposure, and mucosal acid sensitivity are three separate, though related, aspects of gastro-oesophageal reflux disease.
    Howard PJ; Maher L; Pryde A; Heading RC
    Gut; 1991 Feb; 32(2):128-32. PubMed ID: 1864528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased esophageal sensitivity to acid and saline in patients with nonerosive gastro-esophageal reflux disease.
    Nagahara A; Miwa H; Minoo T; Hojo M; Kawabe M; Osada T; Kurosawa A; Asaoka D; Terai T; Ohkusa T; Sato N
    J Clin Gastroenterol; 2006; 40(10):891-5. PubMed ID: 17063106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of famotidine on oesophageal sensitivity in gastro-oesophageal reflux disease.
    Marrero JM; de Caestecker JS; Maxwell JD
    Gut; 1994 Apr; 35(4):447-50. PubMed ID: 8174979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of salivation and heartburn in response to the site of acid infusion in the human oesophagus.
    Dutta SK; Agrawal K; Mahmoud MA
    Aliment Pharmacol Ther; 2010 Sep; 32(6):795-800. PubMed ID: 20629975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid-related oesophageal sensitivity, not dysmotility, differentiates subgroups of patients with non-erosive reflux disease.
    Thoua NM; Khoo D; Kalantzis C; Emmanuel AV
    Aliment Pharmacol Ther; 2008 Mar; 27(5):396-403. PubMed ID: 18081729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
    Bautista J; Fullerton H; Briseno M; Cui H; Fass R
    Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal integrity and sensitivity to acid in the proximal esophagus in patients with gastroesophageal reflux disease.
    van Hoeij FB; Weijenborg PW; van den Bergh Weerman MA; van den Wijngaard RM; Verheij J; Smout AJ; Bredenoord AJ
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G117-22. PubMed ID: 27198192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms of gastro-oesophageal reflux disease in elderly people.
    Räihä I; Hietanen E; Sourander L
    Age Ageing; 1991 Sep; 20(5):365-70. PubMed ID: 1755393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD.
    Trimble KC; Pryde A; Heading RC
    Gut; 1995 Jul; 37(1):7-12. PubMed ID: 7672684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced chemoreceptor sensitivity in patients with Barrett's esophagus may be related to age and not to the presence of Barrett's epithelium.
    Grade A; Pulliam G; Johnson C; Garewal H; Sampliner RE; Fass R
    Am J Gastroenterol; 1997 Nov; 92(11):2040-3. PubMed ID: 9362188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease.
    Savarino E; Gemignani L; Pohl D; Zentilin P; Dulbecco P; Assandri L; Marabotto E; Bonfanti D; Inferrera S; Fazio V; Malesci A; Tutuian R; Savarino V
    Aliment Pharmacol Ther; 2011 Aug; 34(4):476-86. PubMed ID: 21671968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.
    Zerbib F; Duriez A; Roman S; Capdepont M; Mion F
    Gut; 2008 Feb; 57(2):156-60. PubMed ID: 17951358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.